Tanja Stamm

Active 2002–2026

134
Papers
21,024
Citations
63
h-index
123
i10-index

Citations

Citations per year for Tanja Stamm2003: 1 citations2004: 6 citations2005: 17 citations2006: 18 citations2007: 35 citations2008: 39 citations2009: 58 citations2010: 74 citations2011: 78 citations2012: 69 citations2013: 58 citations2014: 87 citations2015: 120 citations2016: 122 citations2017: 142 citations2018: 144 citations2019: 647 citations2020: 734 citations2021: 635 citations2022: 546 citations2023: 448 citations2024: 980 citations2025: 400 citations2026: 19 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,249 citing papers, 12.3% of this breakdownUnited Kingdom: 922 citing papers, 9.1% of this breakdownNetherlands: 623 citing papers, 6.1% of this breakdownGermany: 608 citing papers, 6% of this breakdownItaly: 571 citing papers, 5.6% of this breakdownFrance: 493 citing papers, 4.8% of this breakdownChina: 473 citing papers, 4.7% of this breakdownCanada: 373 citing papers, 3.7% of this breakdownJapan: 370 citing papers, 3.6% of this breakdownAustria: 359 citing papers, 3.5% of this breakdownSpain: 351 citing papers, 3.5% of this breakdownAustralia: 270 citing papers, 2.7% of this breakdown
0%12.3%Other 34.4%

Fields

  • Medicine80.9%
  • Biochemistry, Genetics and Molecular Biology4.9%
  • Immunology and Microbiology4.8%
  • Health Professions2.2%
  • Social Sciences1.5%
  • Dentistry1.5%
  • Other4.2%

Topics

  • Rheumatoid Arthritis Research and Therapies20.4%
  • Spondyloarthritis Studies and Treatments8.2%
  • Autoimmune and Inflammatory Disorders Research5.9%
  • Systemic Lupus Erythematosus Research4.7%
  • Psoriasis: Treatment and Pathogenesis2.6%
  • Osteoarthritis Treatment and Mechanisms2.1%
  • Other56.1%

Coauthors

All papers

Open in search
  1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Annamaria Iagnocco, Kim Lauper, Zhanguo Li, Iain B. McInnes, Eduardo Mysler, Peter Nash, Gyula Poór, Gorica Ristić, Felice Rivellese, Andrea Rubbert‐Roth, Hendrik Schulze‐Koops, Nikolay Stoilov, Anja Strangfeld, Annette H M van der Helm–van Mil, Elsa van Duuren, T. P. M. Vliet Vlieland, René Westhovens, Désirée van der Heijde - Annals of the Rheumatic Diseases 2022 cited by 1,788

  2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marios Kouloumas, Tore Kvien, Zhanguo Li, Xavier Mariette, Iain B. McInnes, Eduardo Mysler, Peter Nash, Karel Pavelká, Gyula Poór, Christophe Richez, Piet L. C. M. van Riel, Andrea Rubbert‐Roth, Kenneth G. Saag, José António Pereira da Silva, Tanja Stamm, Tsutomu Takeuchi, René Westhovens, Maarten de Wit, Désirée van der Heijde - Annals of the Rheumatic Diseases 2017 cited by 5,775

  3. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marios Kouloumas, Robert Landewé, E. Martín‐Mola, Peter Nash, Mikkel Østergaard, Andrew J.K. Östör, P. Scott Richards, Tuulikki Sokka‐Isler, Carter Thorne, Athanasios G. Tzioufas, Ronald van Vollenhoven, M. De Wit, Désirée van der Heijde - Annals of the Rheumatic Diseases 2015 cited by 1,458

  4. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher T. Ritchlin, Martín Rudwaleit, Adrian Tanew, Bing Thio, Douglas J. Veale, Kurt de Vlam, Désirée van der Heijde - Annals of the Rheumatic Diseases 2017 cited by 676

  5. Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

    Authors: , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2022 cited by 168

  6. 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases

    Authors: , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2022 cited by 241

  7. 2018 update of the EULAR recommendations for the management of hand osteoarthritis

    Authors: , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2018 cited by 493

  8. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

    Authors: , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2022 cited by 139

  9. 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis

    Authors: , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2021 cited by 309

  10. EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2023 cited by 116

  11. American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision

    Authors: , , , , , , , - Annals of the Rheumatic Diseases 2022 cited by 131

  12. EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2023 cited by 120

  13. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score

    Authors: , , , , , , - Arthritis Research & Therapy 2005 cited by 1,076

  14. Consensus recommendations on how to assess the quality of surgical interventions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marie‐Pascale Pomey, Susan M. Webb, Panel 2, Felix Berlth, J.M. Ramia, Roxane D. Staiger, Kathy Sienko, Marit S. de Vos, Henrik Kehlet, Philip C. Müller, Panel 3, Martin F. Fey, Susan O’Reilly, René Vonlanthen, Panel 4, Andrew C. von Eschenbach, Jeffrey V. Lazarus, Zeynep Or, Clifford Y. Ko, Panel 5, Mia Aurelia Huber, Jonathan Ives, Tanja Krones, Robert D. Truog, Sridhar Venkatapuram, Panel 6, Jad Abou‐Khalil, Julio F. Fiore, Cesar A. Hincapié, Norihiro Kokudo, Timothy M. Pawlik, Panel 7, Mark Adams, Joel Armitage, Anne Lübbeke, Patricia Sánchez‐Velázquez, Reto A. Schuepbach, Alicja Zientara, Marit Kalisvaart, Daniel A. Hofmaenner, Jean‐Daniel Chiche, Alexander Jackson, Ramani Moonesinghe, Panel 8, Fariba Abbassi, Bernice S. Elger, Alexander Joeris, Fabia Rothenfluh, Felix Schneuwly, Yuki Seidler, Guru Sivaraman, Panel 9, Tala Ballouz, Ana Costa-Ramón, Rebecca A. Snyder, Mirriam Tyebally Fang, Claudia M. Witt - Nature Medicine 2023 cited by 93

  15. Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John D. Isaacs, Joel M. Kremer, Xavier Mariette, Peter A. Merkel, Eduardo Mysler, Peter Nash, Michael T. Nurmohamed, Karel Pavelká, Gyula Poór, Andrea Rubbert‐Roth, Hendrik Schulze‐Koops, Anja Strangfeld, Yoshiya Tanaka, Josef S Smolen - Annals of the Rheumatic Diseases 2022 cited by 69

  16. 2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2022 cited by 133

  17. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2014 cited by 421

  18. RECOMMENDATIONS FOR USE AND SCORING OF ORAL HEALTH IMPACT PROFILE VERSIONS

    Authors: , , , , , , , , , , , , , , , , , - Journal of Evidence Based Dental Practice 2021 cited by 124

  19. Determinants of COVID-19 vaccine fatigue

    Authors: , , , , , , - Nature Medicine 2023 cited by 82

  20. Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

    Authors: , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2022 cited by 103

  21. The Roadmap for Implementing Value-Based Healthcare in European University Hospitals—Consensus Report and Recommendations

    Authors: , , , , , , , , , , , , , , , - Value in Health 2021 cited by 73

  22. Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs

    Authors: , , , , , , , , , , , , , , , , , , - RMD Open 2022 cited by 71

  23. Remission and active disease in rheumatoid arthritis: Defining criteria for disease activity states

    Authors: , , , , , - Arthritis & Rheumatism 2005 cited by 548

  24. Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs

    Authors: , , , , , , , , , , , , , , , , , , - RMD Open 2022 cited by 84